Recurrence pattern analysis after [68Ga]-DOTATATE-PET/CT-planned radiotherapy of high-grade meningiomas

被引:19
|
作者
Zollner, Barbara [1 ]
Ganswindt, Ute [1 ]
Maihoefer, Cornelius [1 ]
Corradini, Stefanie [1 ]
Albert, Nathalie Lisa [2 ]
Schichor, Christian [3 ]
Belka, Claus [1 ,4 ,5 ]
Niyazi, Maximilian [1 ,4 ,5 ]
机构
[1] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Radiat Oncol, Marchioninistr 15, D-81377 Munich, Germany
[2] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Nucl Med, Marchioninistr 15, D-81377 Munich, Germany
[3] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Neurosurg, Marchioninistr 15, D-81377 Munich, Germany
[4] German Canc Consortium DKTK, Partner Site Munich, Munich, Germany
[5] German Canc Res Ctr, Heidelberg, Germany
来源
RADIATION ONCOLOGY | 2018年 / 13卷
关键词
Atypical and anaplastic meningioma; Radiotherapy; Recurrence pattern; Safety margin; IMRT; STEREOTACTIC RADIOTHERAPY; ANAPLASTIC MENINGIOMAS; ADJUVANT RADIOTHERAPY; PROTON THERAPY; DIAGNOSIS; SURVIVAL; FAILURE; CLASSIFICATION; IRRADIATION; TUMORS;
D O I
10.1186/s13014-018-1056-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The aim of the present study was to evaluate the influence of the applied safety margins of modern intensity-modulated radiotherapy (IMRT) in patients with high-grade meningiomas on local control and recurrence patterns. Methods: Twenty patients with a neuropathological diagnosis of a high-grade meningioma (WHO degrees II or degrees III) treated with adjuvant or definitive radiotherapy between 2010 and 2015 were included in the present retrospective analysis. All patients were planned PET-based. Recurrence patterns were assessed by means of MRI and/or DOTATATE-PET/computertomography (CT). Results: The median follow-up was 31.0 months [95% confidence interval (CI): 20.1-42.0] and the progressionfree survival (PFS) after 24 months was 87.5%. Overall, four patients had a local recurrence of their meningioma. Of these, three were located in field according to the prior radiotherapy treatment region, while only one patient had a distant relapse. There were no independent factors influencing progression-free or overall survival (OS). Conclusion: After radiotherapy (RT), patients with atypical or anaplastic meningiomas still have a defined risk of tumor recurrence. The aim of the present study was to examine mono-institutional data concerning target volume definition and recurrence patterns after radiotherapy of high-grade meningiomas as there are limited data available. Our data suggest that extended safety margins are necessary to achieve a favorable local control for high-grade meningiomas.
引用
收藏
页数:9
相关论文
共 13 条
  • [1] Recurrence pattern analysis after [68Ga]-DOTATATE-PET/CT -planned radiotherapy of high-grade meningiomas
    Barbara Zollner
    Ute Ganswindt
    Cornelius Maihöfer
    Stefanie Corradini
    Nathalie Lisa Albert
    Christian Schichor
    Claus Belka
    Maximilian Niyazi
    Radiation Oncology, 13
  • [2] Somatostatin receptor subtype 2 in high-grade gliomas: PET/CT with 68Ga-DOTA-peptides, correlation to prognostic markers, and implications for targeted radiotherapy
    Kiviniemi, Aida
    Gardberg, Maria
    Frantzen, Janek
    Pesola, Marko
    Vuorinen, Ville
    Parkkola, Riitta
    Tolvanen, Tuula
    Suilamo, Sami
    Johansson, Jarkko
    Luoto, Pauliina
    Kemppainen, Jukka
    Roivainen, Anne
    Minn, Heikki
    EJNMMI RESEARCH, 2015, 5
  • [3] Ga-68 PSMA PET/CT in recurrent high-grade gliomas: evaluating PSMA expression in vivo
    Kumar, Arunav
    ArunRaj, Sreedharan Thankarajan
    Bhullar, Khush
    Haresh, K. P.
    Gupta, Subhash
    Ballal, Sanjana
    Yadav, Madhav
    Singh, Manmohan
    Damle, Nishikant Avinash
    Garg, Ajay
    Tripathi, Madhavi
    Bal, Chandrasekhar
    NEURORADIOLOGY, 2022, 64 (05) : 969 - 979
  • [4] Recurrence pattern after [(18)F]Fluoroethyltyrosine-Positron Emission Tomography-guided radiotherapy for high-grade glioma: A prospective study
    Weber, Damien C.
    Casanova, Nathalie
    Zilli, Thomas
    Buchegger, Franz
    Rouzaud, Michel
    Nouet, Philippe
    Vees, Hansjorg
    Ratib, Osman
    Dipasquale, Giovanna
    Miralbell, Raymond
    RADIOTHERAPY AND ONCOLOGY, 2009, 93 (03) : 586 - 592
  • [5] The significance of metabolic response to neoadjuvant androgen deprivation therapy detected with [68Ga]Ga-PSMA-11-PET/CT in high-risk prostate cancer patients treated with definitive radiotherapy
    Onal, Cem
    Guler, Ozan Cem
    Torun, Nese
    Oymak, Ezgi
    Reyhan, Mehmet
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (12) : 3755 - 3764
  • [6] 68Ga-PSMA PET/CT-based metastasis-directed radiotherapy for oligometastatic prostate cancer recurrence after radical prostatectomy
    Artigas, C.
    Flamen, P.
    Charlier, F.
    Levillain, H.
    Wimana, Z.
    Diamand, R.
    Albisinni, S.
    Gil, T.
    Van Velthoven, R.
    Peltier, A.
    Van Gestel, D.
    Roumeguere, T.
    Otte, F. -X.
    WORLD JOURNAL OF UROLOGY, 2019, 37 (08) : 1535 - 1542
  • [7] 18F-FAZA PET/CT Hypoxia Imaging of High-Grade Glioma Before and After Radiotherapy
    Mapelli, Paola
    Zerbetto, Flavia
    Incerti, Elena
    Conte, Gian Marco
    Bettinardi, Valentino
    Fallanca, Federico
    Anzalone, Nicoletta
    Di Muzio, Nadia
    Gianolli, Luigi
    Picchio, Maria
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (12) : E525 - E526
  • [8] 68Ga-PSMA PET/CT in Initial Diagnosis and Bone Metastasis Evaluation in Saudi Patients with High-Grade Prostate Cancer
    Mansour, Sahar
    Al-Khalaf, Meshael
    Al-Hantoshi, Sarah
    Al-Mutairi, Mead
    Al-Asqah, Fatima
    Al-Subaie, Nouf
    Al-Qarni, Sadeem
    Suwaylim, Futun
    Alkhodiri, Rawan F.
    Faden, Ola
    Albatly, Abdulrahman
    INTERNATIONAL JOURNAL OF BIOMEDICINE, 2024, 14 (01) : 72 - 76
  • [9] 68Ga-PSMA PET/CT-based metastasis-directed radiotherapy for oligometastatic prostate cancer recurrence after radical prostatectomy
    C. Artigas
    P. Flamen
    F. Charlier
    H. Levillain
    Z. Wimana
    R. Diamand
    S. Albisinni
    T. Gil
    R. Van Velthoven
    A. Peltier
    D. Van Gestel
    T. Roumeguere
    F.-X. Otte
    World Journal of Urology, 2019, 37 : 1535 - 1542
  • [10] PET/CT using 68Ga-PSMA-617 versus 18F-fluorodeoxyglucose to differentiate low- and high-grade gliomas
    Liu, Daliang
    Cheng, Guang
    Ma, Xiaowei
    Wang, Shuailiang
    Zhao, Xiaohu
    Zhang, Wei
    Yang, Weidong
    Wang, Jing
    JOURNAL OF NEUROIMAGING, 2021, : 733 - 742